PD-1/PD-L1 Inhibitors in Advanced and Metastatic Esophageal Carcinoma: An Updated Meta-Analysis of Randomized Controlled Trials
07:30am - 03:45pm EDT - April 1, 2023




Author(s):
Tags: Clinical Oncology

Display Label Action
PD1 PDL1 Inhibitors NCCN Poster.pdf Download Handout